Scalable treatment solutions for contract manufacturers handling multiple products and varying waste streams.
Treat high-COD pharmaceutical wastewater with strong organic loads.
Wastewater treatment for pharmaceutical formulation plants. Handle excipients, cleaning agents and product residues.
Treat biopharmaceutical wastewater from fermentation and cell culture.
GMP-compliant wastewater treatment for pharmaceutical facilities.
Contract manufacturers produce multiple products for different clients, creating highly variable wastewater streams with composition that changes between campaigns.
Wastewater streams frequently carry organic loads 5-50x higher than domestic sewage, demanding robust biological or physical-chemical treatment capacity.
Temperature, pH, flow, and concentration swings between production shifts create treatment instability without proper equalisation and buffering.
Shock loads, toxins, or pH extremes can kill beneficial biomass. Protection mechanisms like equalisation and pH correction are essential.
High FOG content causes pipe blockage, flotation cell failure, and membrane fouling. Effective pre-treatment prevents downstream operational issues.
Variable chemical composition from cleaning agents, process chemicals, and raw materials requires adaptable treatment chemistry and dosing control.
Discharge consents are tightening continuously. Treatment must not only meet current limits but accommodate future reductions without major rebuild.
Our CMO treatment systems include large equalization capacity, robust multi-stage treatment, and flexible operation mode
Standardised skid-mounted and containerised units bolt together to increase capacity. Additional tanks, blowers, or filters added in parallel without process interruption.
Aeration systems, pipework, and electrical supplies sized for 130-150% of initial capacity. Future expansion requires only additional process units, not infrastructure replacement.
PLC and SCADA systems designed with spare I/O capacity for additional instruments and equipment. Software updates enable expanded functionality without hardware replacement.
Initial installation treats current flow with civil works and utilities sized for future expansion. Additional trains installed during scheduled shutdowns when demand grows.
Each expansion module carries its own performance guarantee. Existing treatment continues under warranty while new capacity is commissioned and validated independently.
Phased Capital expenditure spread across multiple budget years. Initial investment reduced while maintaining ability to meet regulatory obligations as production increases.
Treatment systems support client audits and regulatory inspections with complete documentation. Performance validation d
We manage discharge permit applications, amendments, and renewals. Environmental regulators trust our data and engineering credibility, speeding approvals.
Effluent sampling follows ISO and national standards. Third-party laboratory analysis provides defensible data for regulatory submissions and legal defence.
Continuous data logging, calibration records, and maintenance logs are organised for instant retrieval. Environmental audits become routine, not stressful events.
We design for 50-70% of the consent limit, not 100%. This safety margin absorbs process upsets, seasonal variation, and instrument drift without breach.
Performance guarantees with financial backing shift liability from your balance sheet to ours. Insurance and bonding protect against worst-case scenarios.
Design, fabrication, and commissioning follow ISO, EN, and industry-specific standards. Documentation packages satisfy due diligence for lenders and insurers.
Ozonation and O3/UV advanced oxidation for Colour removal, odour control, and micropollutant destruction in industrial wastewater.
View PageDirectory of international wastewater treatment regulations and equipment compliance standards Organised by country and region.
View PageWastewater treatment for active pharmaceutical ingredient manufacturing.
View PagePharmaceutical manufacturing generates complex wastewaters containing active pharmaceutical ingredients (APIs), solvents, high organic loads, and variable pH. Our treatment trains combine advanced oxidation, specialised biological degradation, and precision separation to achieve discharge consent while protecting downstream municipal treatment works from potent compound disruption.
Advanced oxidation and photo-Fenton processes mineralise recalcitrant pharmaceutical compounds.
Vacuum distillation and membrane separation recover valuable solvents for re-use or resale.
Specialised biomass acclimated to pharmaceutical wastewaters resists shock loading.
Full IQ/OQ/PQ documentation packages for validated manufacturing environments.
| COD Range | 2,000 – 50,000 mg/L |
| BOD/COD Ratio | 0.3 – 0.6 (biodegradable fraction) |
| pH Variation | 2.0 – 12.0 (acid/alkali cleaning cycles) |
| TDS Loading | Up to 80,000 mg/L (brine and buffer salts) |
| Temperature | 15 – 45°C (process dependent) |
| HRT Bioreactor | 24 – 72 hours (extended for recalcitrant COD) |
| Sludge Yield | 0.4 – 0.8 kg DS/kg COD removed |
| Materials | SS316L, duplex, PTFE-lined (solvent resistance) |
Environmental risk assessment and ERA compliance for API manufacturing discharge.
Qualified equipment and validated cleaning procedures for multiproduct facilities.
Water quality meets EP, USP, and JP requirements for purified and Water for Injection.
Our experts can design a system tailored to your specific requirements.
Our expertise spans multiple industries with sector-specific water treatment solutions.